ORKA · Oruka Therapeutics, Inc.
$102.65
-5.32 (-4.92%)
At close · Aug 24
Market Cap
$7.15B
Shares
66.21M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2023
Net Income
-$105.43M
-25.9%
FY2025
Diluted EPS
-$3.87
+12.8%
FY2024
Operating Cash Flow
-$88.21M
-52.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | |
| $129.03M | $100.64M | $75.06M | $1.01M | $4.75M | $13.83M | $4.99M | $1.83M | $4.24M | $14.08M | $12.35M | $7.06M | $5.63M | $2.93M | $1.09M | $2.32M | $3.11M | — | — | — | — | — | — | |
| $26.05M | $21.41M | $13.06M | $6.28M | $5.85M | $5.5M | $4.77M | $3.98M | $3.88M | $4.64M | $4.27M | $4.39M | $4.07M | $4.01M | — | — | — | — | — | — | — | — | — | |
| $4.2M | — | — | — | — | — | — | — | — | — | — | — | — | $4.01M | $3.23M | $5.05M | $6.07M | — | — | — | — | — | — | |
| — | — | — | $15K | $20K | $16K | $8000 | $18K | $22K | $27K | $24K | $19K | $12K | $26K | $43K | $602K | $338K | — | — | — | — | — | — | |
| $155.08M | $122.05M | $88.12M | $7.3M | $10.6M | $19.34M | $9.77M | $5.81M | $8.12M | $18.71M | $16.61M | $11.46M | $9.69M | $6.94M | $4.32M | $7.36M | $9.18M | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | $9.69M | $6.94M | — | — | — | — | — | — | — | — | — | |
| -$155.08M | -$122.05M | -$88.12M | -$7.3M | -$10.6M | -$19.34M | -$9.77M | -$5.81M | -$8.12M | -$18.71M | -$16.61M | -$11.46M | -$9.69M | -$6.94M | -$4.32M | -$7.36M | -$9.18M | — | — | — | — | — | — | |
| — | — | — | -$7.28M | -$10.58M | -$19.32M | -$9.76M | -$5.8M | -$8.1M | -$18.69M | -$16.59M | -$11.44M | -$9.68M | -$6.91M | -$4.28M | -$6.76M | -$8.84M | — | — | — | — | — | — | |
| — | $1.47M | $1.47M | — | — | — | $9000 | $7000 | $8000 | $6000 | — | $4000 | $3000 | $4000 | — | — | — | — | — | — | — | — | — | |
| $22.18M | $16.63M | $5.86M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $22.19M | $16.62M | $4.4M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$105.43M | -$83.72M | — | — | -$19.32M | -$9.75M | -$5.65M | -$7.96M | -$18.55M | -$16.44M | — | — | -$6.94M | -$4.32M | -$5.36M | -$8.42M | — | — | — | — | — | — | |
| $0 | — | — | $0 | $0 | $0 | -$9000 | -$167K | -$31K | -$61K | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| -$132.89M | -$105.43M | -$83.72M | -$5.34M | -$9.93M | -$19.32M | -$9.74M | -$5.48M | -$7.93M | -$18.49M | -$16.44M | -$11.45M | -$9.69M | -$6.94M | -$4.32M | -$5.36M | -$8.42M | -$9.14M | -$19.43M | -$13.99M | -$5.24M | -$1.46M | -$511K | |
| — | — | — | — | — | — | — | — | — | — | — | — | -$9.69M | -$8.97M | -$4.32M | -$5.36M | -$8.42M | — | — | — | — | — | — | |
| -$134.56M | -$104.85M | -$83.77M | — | — | — | — | -$5.48M | -$7.93M | -$18.47M | -$16.46M | -$11.45M | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | — | -$3.87 | -$4.44 | -$8.28 | -$16.68 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | — | -$3.87 | -$4.44 | -$8.28 | -$16.68 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | — | 16.79M | 1.2M | 1.2M | 1.16M | 392.52K | 110.1K | 64.12K | 869.28K | 755.62K | 524.11K | 1.71M | 719.31K | 185.52K | 139.65K | — | — | — | — | — | — | — |
| shares | — | — | 16.79M | 1.2M | 1.2M | 1.16M | 392.52K | 110.1K | 64.12K | 869.28K | 755.62K | 524.11K | 244.06K | 719.12K | 185.29K | 139.42K | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 9.86×
EV/EBIT
—
Peer median 26.30×
P/E (TTM)
—
Peer median 19.81×
Peer medians compare against the 166 similar-size Biotechnology companies (of 533 listed).
Key facts
CIK
907654
CUSIP
687604108
13F (30d)
236 filings
232 filers
Visit website
Investor relations